Forte Biosciences's total assets for Q4 2025 were $82.78M, an increase of 23.14% from the previous quarter. FBRX total liabilities were $21.79M for the fiscal quarter, a -13.27% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.